Recent acquisitions in acquired and congenital von Willebrand disorders

Clinica Chimica Acta

Volumn 377, Issue 1-2, 2007, Pages 62-69

  Franchini, Massimo ^a   Lippi, Giuseppe ^b  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b Istituto di Chimica   (Italy)

Author keywords

Acquired von Willebrand syndrome; Bleeding; von Willebrand disease; von Willebrand factor

Indexed keywords

ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 8 CONCENTRATE; CIPROFLOXACIN; CORTICOSTEROID; DESMOPRESSIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A; VON WILLEBRAND FACTOR;

ARTERY THROMBOSIS; BLEEDING; BLOOD TRANSFUSION; CLINICAL FEATURE; CONTINUOUS INFUSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; FLUID OVERLOAD; FLUSHING; HUMAN; HYPONATREMIA; LABORATORY DIAGNOSIS; PATHOPHYSIOLOGY; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIDE EFFECT; TACHYCARDIA; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE;

BIOLOGICAL MARKERS; HUMANS; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 33845468341     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.10.017     Document Type: Review

References (104)

1. Sadler J.E. von Willebrand factor: two sides of a coin. J Thromb Haemost 3 (2005) 1702-1709
2. Martinelli I. von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis. Semin Hematol 42 (2005) 49-55
3. Ruggeri Z.M. Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation. Best Pract Res Clin Haematol 14 (2001) 257-279
4. Mancuso D.J., Tuley E.A., Westfield L.A., et al. Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction. Biochemistry 30 (1991) 253-269
5. Castaman G., Federici A.B., Rodeghiero F., and Mannucci P.M. von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica 88 (2003) 94-108
6. Sadler J.E., Mancuso D.J., Randi A.M., Tuley E.A., and Westfield LA. Molecular biology of von Willebrand factor. Ann N Y Acad Sci 614 (1991) 114-124
7. Wagner D.D. Cell biology of von Willebrand factor. Annu Rev Cell Biol 6 (1990) 217-246
8. Ruggeri Z.M. Von Willebrand factor. Curr Opin Hematol 10 (2003) 142-149
9. Dong J.F., Moake J.L., Nolasco L., et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 100 (2002) 4033-4039
10. Vlot A.J., Koppelman S.J., Bouma B.N., and Sixma J.J. Factor VIII and von Willebrand factor. Thromb Haemost 79 (1998) 456-465
11. Gill J.C., Endres-Brooks J., Bauer P.J., Marks Jr. W.J., and Montgomery R.R. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 69 (1987) 1691-1695
12. Rodeghiero F., Castaman G., and Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 69 (1987) 454-459
13. Federici A.B., Castaman G., and Mannucci P.M. Italian Association of Hemophilia Centers (AICE). Guidelines for the diagnosis and management of von Willebrand disease in Italy. Haemophilia 8 (2002) 607-621
14. Sadler J.E. A revised classification of von Willebrand disease. Thromb Haemost 71 (1994) 520-525
15. Federici A.B. Clinical diagnosis of von Willebrand disease. Haemophilia 10 Suppl 4 (2004) 169-176
16. Miller C.H., Graham J.B., Goldin L.R., and Elston R.C. Genetics of classic von Willebrand's disease. I. Phenotypic variation within families. Blood 54 (1979) 117-136
17. Rodeghiero F., Castaman G., Tosetto A., et al. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost 3 (2005) 2619-2626
18. Mannucci P.M., Lombardi R., Bader R., et al. Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor. Blood 66 (1985) 796-802
19. Favaloro E.J., Lillicrap D., Lazzari M.A., et al. von Willebrand disease: laboratory aspects of diagnosis and treatment. Haemophilia 10 Suppl. 4 (2004) 164-168
20. Laffan M., Brown S.A., Collins P.W., et al. The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization. Haemophilia 10 (2004) 199-217
21. Miller J.L., and Castella A. Platelet-type von Willebrand's disease: characterization of a new bleeding disorder. Blood 60 (1982) 790-794
22. Nishino M., Girma J.P., Rothschild C., Fressinaud E., and Meyer D. New variant of von Willebrand disease with defective binding to factor VIII. Blood 74 (1989) 1591-1599
23. Mazurier C., Dieval J., Jorieux S., Delobel J., and Goudemand M. A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction. Blood 75 (1990) 20-26
24. Franchini M. The platelet function analyzer (PFA-100): an update on its clinical use. Clin Lab 51 (2005) 367-372
25. Federici A.B., Canciani M.T., Forza I., and Cozzi G. Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease-single center comparison of four different assays. Thromb Haemost 84 (2000) 1127-1128
26. Meyer D., Fressinaud E., Gaucher C., et al. Gene defects in 150 unrelated French cases with type 2 von Willebrand disease: from the patient to the gene. INSERM Network on Molecular Abnormalities in von Willebrand Disease. Thromb Haemost 78 (1997) 451-456
27. Mannucci P.M., Ruggeri Z.M., Ciavarella N., Kazatchkine M.D., and Mowbray J.F. Precipitating antibodies to factor VIII/von Willebrand factor in von Willebrand's disease: effects on replacement therapy. Blood 57 (1981) 25-31
28. Pasi K.J., Collins P.W., Keeling D.M., et al. Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization. Haemophilia 10 (2004) 218-231
29. Mannucci P.M. Treatment of von Willebrand's Disease. N Engl J Med 351 (2004) 683-694
30. Mannucci P.M., and Federici A.B. Management of inherited von Willebrand disease. Best Pract Res Clin Haematol 14 (2001) 455-462
31. Rodeghiero F., Castaman G., and Mannucci P.M. Clinical indications for desmopressin (DDAVP) in congenital and acquired von Willebrand disease. Blood Rev 5 (1991) 155-161
32. Mannucci P.M. How I treat patients with von Willebrand disease. Blood 97 (2001) 1915-1919
33. Mannucci P.M. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years. Haemophilia 6 Suppl 1 (2000) 60-67
34. Mannucci P.M., Chediak J., Hanna W., et al. Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study. Blood 99 (2002) 450-456
35. Franchini M., Rossetti G., Tagliaferri A., et al. Efficacy and safety of factor VIII/ von Willebrand factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand's disease. Haematologica 88 (2003) 1279-1283
36. Mannucci P.M. Venous thromboembolism in von Willebrand disease. Thromb Haemost 88 (2002) 378-379
37. Makris M., Colvin B., Gupta V., Shields M.L., and Smith M.P. Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand's disease. Thromb Haemost 88 (2002) 387-388
38. Rodeghiero F., and Castaman G. Treatment of von Willebrand disease. Semin Hematol 42 (2005) 29-35
39. Mannucci P.M., Tamaro G., Narchi G., et al. Life-threatening reaction to factor VIII concentrate in a patient with severe von Willebrand disease and alloantibodies to von Willebrand factor. Eur J Haematol 39 (1987) 467-470
40. Handin R.I., Martin V., and Maloney W.C. Antibody induced von Willebrand syndrome. A newly defined inhibitor syndrome. Blood 48 (1976) 393
41. Cohen A.J., and Kessler C.M. Auto-antibody against inhibitors of von Willebrand factor protein. Bailliere's Clin Haematol 9 (1996) 348-354
42. Rinder M.R., Richard R.E., and Rinder H.M. Acquired von Willebrand disease: a concise review. Am J Haematol 54 (1997) 139-145
43. Tefferi A., and Nichols W.L. Acquired von Willebrand disease: concise review of occurrence, diagnosis, pathogenesis and treatment. Am J Med 103 (1997) 536-540
44. Veyradier A., Jenkins C.S., Fressinaud E., and Meyer D. Acquired von Willebrand syndrome: from pathophysiology to management. Thromb Haemost 84 (2000) 175-182
45. Federici A.B., Budde U., and Rand J.H. Acquired von Willebrand syndrome 2004: international registry. Hämostaseologie 24 (2004) 50-55
46. Simone J.V., Cornet J.A., and Abildgaard C.F. Acquired von Willebrand's syndrome in systemic lupus erythematous. Blood 31 (1968) 806-812
47. Federici A.B., Rand J.H., Bucciarelli P., et al. Subcommittee on von Willebrand Factor. Acquired von Willebrand syndrome: data from an International registry. Thromb Haemost 84 (2000) 345-349
48. Budde U., Bergemann F., and Michiels J.J. Acquired von Willebrand syndrome: experience from 2 years in a single laboratory compared with data from the literature and an international registry. Sem Thromb Hemost 28 (2002) 227-238
49. Mannucci P.M., Lombardi R., and Bader R. Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gamopathies. Blood 64 (1984) 614-621
50. Mant M.J., Hirsch J., Gauldie J., Bienenstock J., Pineo J., and Luke K.H. Von Willebrand's syndrome presenting as an acquired bleeding disorder in association with a monoclonal gammopathy. Blood 42 (1973) 429-436
51. Nitu-Whalley I.C., and Lee C.A. Acquired von Willebrand syndrome - report of 10 cases and review of the literature. Haemophilia 5 (1999) 318-326
52. Federici A.B., Rand J.H., and Mannucci P.M. Acquired von Willebrand syndrome: an important bleeding complication to be considered in patients with lymphoproliferative and myeloproliferative disorders. Hematol J 2 (2001) 358-362
53. Richard C., Cuardo M.A., and Prieto M. Acquired von Willebrand disease myeloma secondary to absorption of von Willebrand factor by plasma cells. Am J Haematol 35 (1990) 114-117
54. Mohri H., Tanabe J., Ohtsuka M., et al. Acquired von Willebrand disease associated with multiple myeloma; characterization of an inhibitor to von Willebrand factor. Blood Coagul Fibrinolysis 6 (1995) 561-566
55. Mazurier C., Parquet-Gernez A., Descamps J., Bauters F., and Goudeman M. Acquired von Willebrand's syndrome in the course of Waldenstrom disease. Thromb Haemost 44 (1980) 115
56. Wautier J.L., Levy-Toledano S., and Caen J.P. Acquired von Willebrand's syndrome and thrombopathy in patient with chronic lymphocytic leukemia. Scand J Haematol 16 (1976) 128-134
57. Roussi J.H., Houbouyan L.L., Alterescu L., Franc B., and Goguel A.F. Acquired von Willebrand's syndrome associated with hairy cell leukemia. Br J Haematol 46 (1980) 503-506
58. Tran-Thang C., Mannucci P.M., Schneider P., Federici A., and Bachmann F. Profound alterations of the multimeric structure of von Willebrand factor in a patient with malignant lymphoma. Br J Haematol 61 (1985) 307-314
59. Tefferi A., Hanson C.A., Kurtin P.J., Katzmann J.A., Dalton R.J., and Nichols W.L. Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells. Br J Haematol 96 (1997) 850-853
60. Raman B.K.S., Sawdyk M., and Saced S.M. Essential thrombocythemia with acquired von Willebrand's disease. Am J Clin Pathol 88 (1987) 102-106
61. van Genderen P.J.J., Michiels J.J., van der Poel-van de Luytgaarde S.C., and van Vliet H.H. Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet count. Ann Hematol 69 (1994) 81-84
62. Budde U., and van Genderen P.J.J. Acquired von Willebrand disease in patients with high platelet counts. Sem Thromb Haemost 23 (1997) 425-431
63. Baud P., Tobler A., Lämmle B., and Alberio L. Acquired von Willebrand syndrome in myeloproliferative disorder. Hämostaseologie 23 (2003) 121-124
64. Mohri H. Acquired von Willebrand's disease in patients with polycythemia rubra vera. Am J Hematol 26 (1987) 135-146
65. Mohri H. Acquired von Willebrand's disease and storage pool disease in chronic myelocytic leukemia. Am J Hematol 22 (1986) 391-401
66. Noronha P.A., Houby M.A., and Maurer H.S. Acquired von Willebrand disease in a patient with Wilm's tumor. J Pediatr 95 (1979) 997-999
67. Scott J.P., Montgomery R.R., Tubergen D.G., and Hays T. Acquired von Willebrand's disease in association with Wilm's tumor: regression after treatment. Blood 58 (1987) 247-257
68. Facon T., Caron C., Courtin P., et al. Acquired type II von Willebrand disease associated with adrenal cortical carcinoma. Brit J Haematol 80 (1992) 488-494
69. Nowak-Göttl U., Kehrel B., Budde U., Hoffman C., Winkelman W., and Jürgens H. Acquired von Willebrand's disease in malignant peripheral neuroectodermal tumor. Med Pediatr Oncol 25 (1995) 117-118
70. Soff G.A., and Green D. Autoantibody to von Willebrand factor in systemic lupus erythematosus. J Lab Clin Med 121 (1992) 424-430
71. Niiya M., Niiya K., Takazawa Y., et al. Acquired type 3-like von Willebrand syndrome preceded full-blown systemic lupus erythematosus. Blood Coagul Fibrinolysis 13 (2002) 361-365
72. Dalton R.G., Savidge G.F., Matthews K.B., et al. Hypothyroidism as a cause of acquired von Willebrand's disease. Lancet 1 (1987) 1007
73. Blessing N.E., Hambley H., and McDonald G.A. Acquired von Willebrand's disease and hypothyroidism: report of a case presenting menorrhagia. Postgrad Med J 66 (1990) 474-476
74. Bruggers C.S., McElligott K., and Rallison M.L. Acquired von Willebrand in twins with autoimmune hypothyroidism: response to desmopressin and l-thyroxine therapy. J Pediatr 125 (1994) 911-913
75. Attivissimo L.A., Lichtman S.M., and Klein I. Acquired von Willebrand syndrome causing a hemorrhagic diathesis in a patient with hypothyroidism. Thyroid 5 (1995) 399-401
76. Franchini M., Zugni C., Veneri D., et al. High prevalence of acquired von Willebrand's syndrome in patients with thyroid diseases undergoing thyroid surgery. Haematologica 89 (2004) 1341-1346
77. Franchini M., Veneri D., and Lippi G. Analysis of thyroid hormone status in 131 consecutive individuals with low von Willebrand factor levels. Thromb Haemost 93 (2005) 392-393
78. Gill J.C., Wilson A.D., Endres-Brooks J., and Montgomery R.R. Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects. Blood 67 (1986) 758-761
79. Vincentelli A., Susen S., Le Tourneau T., et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 349 (2003) 343-349
80. Castaman G., and Rodeghiero F. Acquired transitory von Willebrand syndrome with ciprofloxacin. Lancet 343 (1994) 492
81. Kreuz W., Linde R., Funk M., et al. Induction of von Willebrand disease type I by valproic acid. Lancet 335 (1990) 1350-1351
82. Dalrymphyle-Hay M., Aitchison R., Collins R., Sekhar M., and Calvin B. Hydroxy-ethyl starch induced acquired von Willebrand's disease. Clin Lab Haematol 14 (1992) 209-211
83. Gralnick H.R., McKeown L.P., Williams S.B., Strafer B.C., and Pierce L. Plasma and platelet von Willebrand factor defects in uremia. Am J Med 85 (1988) 806-810
84. Rodeghiero F., Castaman G., Lombardi R., and Mannucci P.M. von Willebrand factor abnormalities in two patients with uraemia. Lancet 1 (1988) 1016-1017
85. Wautier J.L., Caen J.P., and Rymer R. Angiodysplasia in acquired von Willebrand disease. Lancet 2 (1976) 973
86. Cass A.J., Bliss B.P., Bolton R.P., and Cooper B.T. Gastrointestinal bleeding, angiodysplasia of the colon and acquired von Willebrand's disease. Br J Surg 67 (1980) 639-641
87. Inbal A., Bank I., Zivelin A., et al. Acquired von Willebrand disease in a patient with angiodysplasia resulting from immune-mediated clearance of von Willebrand factor. Br J Haematol 96 (1997) 179-182
88. Alhumood S.A., Devine D.V., Lawson L., Nantel S.H., and Carter C.J. Idiopathic immune-mediated acquired von Willebrand's disease in a patient with angiodysplasia: demonstration of an unusual inhibitor causing a functional defect and rapid clearance of von Willebrand factor. Am J Hematol 60 (1999) 151-157
89. Warkentin T.E., Moore C.J., Anand S.S., Lonn E.M., and Morgan D.J. Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome. Transfus Med Rev 17 (2003) 272-286
90. Sokol L., Stueben E.T., Jaikishen J.P., and Lamarche M.B. Turner syndrome associated with acquired von Willebrand disease, primary biliary cirrhosis, and inflammatory bowel disease. Am J Hematol 70 (2002) 257-259
91. Mohri H., Motomura S., and Kanamori H. Clinical significance of inhibitors in acquired von Willebrand syndrome. Blood 91 (1998) 3623-3629
92. Gan T.E., Sawers R.J., and Koutts J. Pathogenesis of antibody-induced acquired von Willebrand syndrome. Am J Hematol 9 (1980) 363-371
93. Pareti F.I., Lattuada A., Bressi C., et al. Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation 102 (2000) 1290-1295
94. Sadler J.E. Aortic stenosis, von Willebrand factor and bleeding. N Engl J Med 349 (2003) 323-325
95. Genderen P.J.J., Boertjes R.C., and Mourik J.A. Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome. Thromb Haemost 80 (1998) 495-498
96. Favaloro E.J., Facey D., and Grispo L. Laboratory assessment of von Willebrand factor. Use of different assays can influence the diagnosis of von Willebrand's disease, dependent on differing sensitivity of sample preparation and differential recognition of high molecular weight VWF forms. Am J Clin Pathol 104 (1995) 264-271
97. Kumar S., Pruthi R.K., and Nichols W.L. Acquired von Willebrand disease. Mayo Clin Proc 77 (2002) 181-187
98. Siaka C., Rugeri L., Caron C., and Goudemand J. A new ELISA assay for diagnosis of acquired von Willebrand syndrome. Haemophilia 9 (2003) 303-308
99. Federici A.B., Stabile F., Castaman G., Canciani M.T., and Mannucci P.M. Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches. Blood 92 (1998) 2707-2711
100. Arkel Y.S., Lynch J., and Kamiyama M. Treatment of acquired von Willebrand syndrome with intravenous immunoglobulin. Thromb Haemost 72 (1994) 643-644
101. Federici A.B. Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome. Hum Immunol 66 (2005) 422-430
102. Silberstein L.E., Abrahm J., and Shattil S.J. The efficacy of intensive plasma exchange in acquired von Willebrand's disease. Transfusion 27 (1987) 234-237
103. Friederich P.W., Wever P.C., Briet E., Doorenbos C.J., and Levi M. Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease. Am J Hematol 66 (2001) 292-294
104. Smaradottir A., and Bona R. A case of acquired von Willebrand syndrome successfully treated with recombinant Factor VIIa during thyroidectomy. Thromb Haemost 93 (2005) 1009